{"brief_title": "Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes", "brief_summary": "This trial is conducted in the United States of America (USA). The purpose of this study is to test whether Biphasic Insulin Aspart 70/30 twice a day with Metformin improves glycemic control vs. once daily Insulin Glargine with Metformin in subjects with Type 2 Diabetes who are inadequately controlled on basal insulin plus oral anti-diabetic therapy.", "condition": "Diabetes Mellitus, Type 2", "intervention_type": "Drug", "intervention_name": "insulin glargine", "criteria": "Inclusion Criteria: - Type 2 Diabetes", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00097877.xml"}